Schloss Wachenheim AG (SWA)
XETRA Stock Exchange · Germany · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 14.75 |
|---|---|
| 52-week range | 13.20 – 16.50 |
| Return, 1 month / 3 months | +0.7% / +7.3% |
| Return, 1 year / 3 years | −0.4% / −1.3% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 46 |
| Volatility (1 year) | 18.8% |
| Worst drawdown (1 year) | -14.0% |
| Average daily value traded | 0.03M EUR |
| Dividend yield | 4.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Schloss Wachenheim is a German wine company based in Trier that makes sparkling wine, sekt and other wine-based drinks. Its brands include Faber, Feist and Schloss Wachenheim, and it also produces non-alcoholic sparkling beverages and dealcoholised wines. The company supplies retailers and consumers in Germany and other European countries, and it operates production sites in several countries. Its products reach both the everyday and the festive table, from budget sparkling wines to branded sekt.
Schloss Wachenheim AG trades under the code SWA on the XETRA Stock Exchange in Germany, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Schloss Wachenheim AG (SWA) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 14.75 on 23 October 2026.
Its price-based Market X-Ray is 67 out of 100 (a fair price profile), ranking 150 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 0.4% and over the last three months it rose 7.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 70 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 3.4% | ||
| From 52-week high | -9.0% | ||
| Momentum | 62 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 7.3% | ||
| 6-month return | 5.0% | ||
| 12-month return, skipping the last month | -1.1% | ||
| Stability (higher is calmer) | 94 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 18.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -14.0% | ||
| Liquidity | 30 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.03M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 61 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 4.1% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −0.3% |
|---|---|
| 1 month | +0.7% |
| 3 months | +7.3% |
| 6 months | +5.0% |
| 1 year | −0.4% |
| 3 years | −1.3% |
| 5 years | −11.8% |
Signals
| 50-day / 200-day average | 14.98 / 14.27 |
|---|---|
| Golden / death cross (60 days) | Golden, 37 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.30 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 20 Nov 2026 | EUR 0.6000 |
| 21 Nov 2025 | EUR 0.6000 |
| 22 Nov 2024 | EUR 0.6000 |
| 17 Nov 2023 | EUR 0.6000 |
| 4 Nov 2022 | EUR 0.6000 |
| 26 Nov 2021 | EUR 0.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.